Search | IOVS | ARVO Journals

Access Provided By:
MIT Libraries

Forgot password?

Create an Account

View

Showing 1 – 9 of 9

SORT: Best Match Most Recent Oldest

VIEW: Basic | Expanded

ARVO Annual Meeting Abstract July 2018

Real-world outcomes of ranibizumab in patients with retinal vein occlusion from the LUMINOUS™ study

Ian Pearce; Soumil Parikh; Wayne Macfadden

Invest. Ophthalmol. Vis. Sci.. 2018; 59(9):2566.

ARVO Annual Meeting Abstract July 2018

Effectiveness of ranibizumab for the treatment of patients with diabetic macular edema in a real-world setting: 1- and 2-year results from the LUMINOUS™ study

Paul Mitchell; Soumil Parikh; Wayne Macfadden

Invest. Ophthalmol. Vis. Sci.. 2018; 59(9):3617.

ARVO Annual Meeting Abstract July 2018

Evaluation of indocyanine green angiographic features in symptomatic macular polypoidal choroidal vasculopathy over 24 months: results from the EVEREST II study

Tock H Lim; Soumil Parikh; Colin S Tan

Invest. Ophthalmol. Vis. Sci.. 2018; 59(9):4480.

ARVO Annual Meeting Abstract July 2018

Evolution over 4 years of enrollment of baseline characteristics of treatment-naïve nAMD patients in the LUMINOUS study

Eric H Souied; Wayne Macfadden; Soumil Parikh

Invest. Ophthalmol. Vis. Sci.. 2018; 59(9):814.

ARVO Annual Meeting Abstract July 2018

Efficacy and safety of ranibizumab with or without verteporfin photodynamic therapy for polypoidal choroidal vasculopathy: 24-month results from the EVEREST II study

Adrian H C Koh; Soumil Parikh

Invest. Ophthalmol. Vis. Sci.. 2018; 59(9):831.

ARVO Annual Meeting Abstract July 2018

Baseline characteristics of the 30,000 patients enrolled in LUMINOUS™, a real-world study with ranibizumab

Christopher Brand; Soumil Parikh; Wayne Macfadden

Invest. Ophthalmol. Vis. Sci.. 2018; 59(9):3902.

ARVO Annual Meeting Abstract July 2018

Ranibizumab treatment for nAMD in clinical practice: outcomes from the LUMINOUS™ study

Sanjay Sharma; Soumil Parikh; Wayne Macfadden

Invest. Ophthalmol. Vis. Sci.. 2018; 59(9):837.

ARVO Annual Meeting Abstract July 2018

Screening failure rates in the EVEREST II clinical trial: challenges in the diagnosis of symptomatic macular polypoidal choroidal vasculopathy

Colin S Tan; Soumil Parikh

Invest. Ophthalmol. Vis. Sci.. 2018; 59(9):2404.

ARVO Annual Meeting Abstract June 2015

Cardiovascular and cerebrovascular safety of ranibizumab (RBZ) in diabetic macular edema (DME): A comprehensive patient-level meta-analysis at month 12

Howard Snow; Natasha Singh; Soumil Parikh; Steven Francom; Cornelia Dunger-Baldauf; Zdenka Haskova; Philippe Margaron; Anthony P Adamis

Invest. Ophthalmol. Vis. Sci.. 2015; 56(7 ):1506.

Advertisement